Basal FSH values are positively associated with aneuploidy incidence in pre-advanced maternal age (AMA) but not in AMA patients.
Advanced maternal age
Aneuploidy
Basal FSH
PGT-A
Journal
Journal of assisted reproduction and genetics
ISSN: 1573-7330
Titre abrégé: J Assist Reprod Genet
Pays: Netherlands
ID NLM: 9206495
Informations de publication
Date de publication:
12 Jul 2024
12 Jul 2024
Historique:
received:
06
03
2024
accepted:
25
06
2024
medline:
12
7
2024
pubmed:
12
7
2024
entrez:
12
7
2024
Statut:
aheadofprint
Résumé
To assess the impact of maternal age on the association between maternal basal FSH and aneuploidy. A retrospective study including data from 1749 blastocysts diagnosed as euploid or aneuploid by PGT-A (preimplantation genetic testing for aneuploidy). Aneuploidy incidence was compared between embryos from mothers with high vs. low basal FSH levels (above and below the group median, respectively) in total, pre-AMA (advanced maternal age; < 35 years, 198 embryos) and AMA (≥ 35 years, 1551 embryos) patient groups, separately. To control for the interference of potentially confounding variables, the association between aneuploidy and high basal FSH levels was assessed by multivariate logistic analysis in overall, pre-AMA and AMA patient groups. Overall, aneuploidy rate was 9% higher (p = 0.02) in embryos from patients with high basal FSH (63.7%) compared to those with low basal FSH (58.4%). In the pre-AMA subgroup, aneuploidy incidence was 35% higher (p = 0.04) in embryos from patients with high basal FSH (53.5%) compared to those with low basal FSH (39.4%). Differently, aneuploidy occurrence did not vary between embryos from AMA patients with low (61.0%) and high (64.8%) basal FSH (p = 0.12). The multivariate analysis revealed that, in pre-AMA embryos, the association between aneuploidy occurrence and high basal FSH is independent of potential confounding variables (p = 0.04). Maternal basal FSH values are associated with embryo aneuploidy in pre-AMA but not in AMA patients. The present findings suggest that basal FSH is a useful parameter to assess aneuploidy risk in pre-AMA patients and reinforce the hypothesis that excessive FSH signalling can predispose to oocyte meiotic errors.
Identifiants
pubmed: 38995508
doi: 10.1007/s10815-024-03190-x
pii: 10.1007/s10815-024-03190-x
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Hunt PA, Hassold TJ. Human female meiosis: what makes a good egg go bad? Trends Genet. 2008;24:86–93. https://doi.org/10.1016/j.tig.2007.11.010 .
doi: 10.1016/j.tig.2007.11.010
pubmed: 18192063
Nagaoka SI, Hassold TJ, Hunt PA. Human aneuploidy: mechanisms and new insights into an age-old problem. Nat Rev Genet. 2012;13:493–504. https://doi.org/10.1038/nrg3245 .
doi: 10.1038/nrg3245
pubmed: 22705668
pmcid: 3551553
Ubaldi FM, Cimadomo D, Vaiarelli A, Fabozzi G, Venturella R, Maggiulli R, Mazzilli R, Ferrero S, Palagiano A, Rienzi L. Advanced maternal age in IVF: still a challenge? The present and the future of its treatment. Front Endocrinol (Lausanne). 2019;10:1–18. https://doi.org/10.3389/fendo.2019.00094 .
doi: 10.3389/fendo.2019.00094
Gardner DK, Sakkas D. Making and selecting the best embryo in the laboratory. Fertil Steril. 2023;120:457–66. https://doi.org/10.1016/j.fertnstert.2022.11.007 .
doi: 10.1016/j.fertnstert.2022.11.007
pubmed: 36521518
Rubio C, Rodrigo L, Garcia-Pascual C, Peinado V, Campos-Galindo I, Garcia-Herrero S, Simon C. Clinical application of embryo aneuploidy testing by next-generation sequencing. Biol Reprod. 2019;101:1083–90. https://doi.org/10.1093/biolre/ioz019 .
doi: 10.1093/biolre/ioz019
pubmed: 30721942
Franasiak JM, Forman EJ, Hong KH, Werner MD, Upham KM, Treff NR, Scott RT Jr. The nature of aneuploidy with increasing age of the female partner: a review of 15,169 consecutive trophectoderm biopsies evaluated with comprehensive chromosomal screening. Fertil Steril. 2014;101:656–63. https://doi.org/10.1016/j.fertnstert.2013.11.004 .
doi: 10.1016/j.fertnstert.2013.11.004
pubmed: 24355045
Gruhn JR, Zielinska AP, Shukla V, Blanshard R, Capalbo A, Cimadomo D, Nikiforov D, Chan AC, Newnham LJ, Vogel I, et al. Chromosome errors in human eggs shape natural fertility over reproductive life span. Science. 2019;365:1466–9. https://doi.org/10.1126/science.aav7321 .
doi: 10.1126/science.aav7321
pubmed: 31604276
pmcid: 7212007
Capalbo A, Hoffmann ER, Cimadomo D, Ubaldi FM, Rienzi L. Human female meiosis revised: new insights into the mechanisms of chromosome segregation and aneuploidies from advanced genomics and time-lapse imaging. Hum Reprod Update. 2017;23:706–22. https://doi.org/10.1093/humupd/dmx026 .
doi: 10.1093/humupd/dmx026
pubmed: 28961822
Yan J, Qin Y, Zhao H, Sun Y, Gong F, Li R, Sun X, Ling X, Li H, Hao C, et al. Live birth with or without preimplantation genetic testing for aneuploidy. N Engl J Med. 2021;385:2047–58. https://doi.org/10.1056/NEJMoa2103613 .
doi: 10.1056/NEJMoa2103613
pubmed: 34818479
Cornelisse S, Zagers M, Kostova E, Fleischer K, van Wely M, Mastenbroek S. Preimplantation genetic testing for aneuploidies (abnormSal number of chromosomes) in in vitro fertilisation. Cochrane Database Syst Rev. 2020;9:CD005291. https://doi.org/10.1002/14651858.CD005291.pub3 .
doi: 10.1002/14651858.CD005291.pub3
pubmed: 32898291
Kucherov A, Fazzari M, Lieman H, Ball GD, Doody K, Jindal S. PGT-A is associated with reduced cumulative live birth rate in first reported IVF stimulation cycles age </= 40: an analysis of 133,494 autologous cycles reported to SART CORS. J Assist Reprod Genet. 2023;40:137–49. https://doi.org/10.1007/s10815-022-02667-x .
doi: 10.1007/s10815-022-02667-x
pubmed: 36454362
Sherman BM, Korenman SG. Hormonal characteristics of the human menstrual cycle throughout reproductive life. J Clin Invest. 1975;55:699–706. https://doi.org/10.1172/JCI107979 .
doi: 10.1172/JCI107979
pubmed: 1120778
pmcid: 301805
Lenton EA, Sexton L, Lee S, Cooke ID. Progressive changes in LH and FSH and LH: FSH ratio in women throughout reproductive life. Maturitas. 1988;10:35–43. https://doi.org/10.1016/0378-5122(88)90129-6 .
doi: 10.1016/0378-5122(88)90129-6
pubmed: 3135465
Tinkanen H, Bläuer M, Laippala P, Tuohimaa P, Kujansuu E. Correlation between serum inhibin B and other indicators of the ovarian function. Eur J Obstet Gynecol Reprod Biol. 2001;94:109–13. https://doi.org/10.1016/S0301-2115(00)00319-5 .
doi: 10.1016/S0301-2115(00)00319-5
pubmed: 11134835
Klein NA, Houmard BS, Hansen KR, Woodruff TK, Sluss PM, Bremner WJ, Soules MR. Age-related analysis of inhibin A, inhibin B, and activin a relative to the intercycle monotropic follicle-stimulating hormone rise in normal ovulatory women. J Clin Endocrinol Metab. 2004;89:2977–81. https://doi.org/10.1210/jc.2003-031515 .
doi: 10.1210/jc.2003-031515
pubmed: 15181087
Klein NA, Illingworth PJ, Groome NP, McNeilly AS, Battaglia DE, Soules MR. Decreased inhibin B secretion is associated with the monotropic FSH rise in older, ovulatory women: a study of serum and follicular fluid levels of dimeric inhibin A and B in spontaneous menstrual cycles. J Clin Endocrinol Metab. 1996;81:2742–5. https://doi.org/10.1210/jcem.81.7.8675606 .
doi: 10.1210/jcem.81.7.8675606
pubmed: 8675606
Hayden TL, Crowley PH, Wilson E. A model relating the incidence of meiotic trisomy to maternal age. J Theor Biol. 1980;86:123–36. https://doi.org/10.1016/0022-5193(80)90070-3 .
doi: 10.1016/0022-5193(80)90070-3
pubmed: 6257985
van Montfrans JM, Dorland M, Oosterhuis GJE, van Vugt JMG, Rekers-Mombarg LTM, Lambalk CB. Increased concentrations of folliclestimulating hormone in mothers of children with Down’s syndrome. The Lancet. 1999;353:1853–4. https://doi.org/10.1016/s0140-6736(99)00936-8 .
doi: 10.1016/s0140-6736(99)00936-8
van Montfrans JM, Van Hooff MHA, Martens F, Lambalk CB. Basal FSH, estradiol and inhibin B concentrations in women with a previous Down’s syndrome affected pregnancy. Hum Reprod. 2002;17:44–7. https://doi.org/10.1093/humrep/17.1.44 .
doi: 10.1093/humrep/17.1.44
pubmed: 11756360
van Montfrans JM, van Hooff MHA, Huirne JA, Tanahatoe SJ, Sadrezadeh S, Martens F, van Vugt JMG, Lambalk CB. Basal FSH concentrations as a marker of ovarian ageing are not related to pregnancy outcome in a general population of women over 30 years. Hum Reprod. 2004;19. https://doi.org/10.1093/humrep/deh088 .
Dursun P, Gultekin M, Yuce K, Ayhan A. What is the underlying cause of aneuploidy associated with increasing maternal age? Is it associated with elevated levels of gonadotropins? Med Hypotheses. 2006;66:143–7. https://doi.org/10.1016/j.mehy.2004.10.022 .
doi: 10.1016/j.mehy.2004.10.022
pubmed: 16140466
Buratini J, Dellaqua TT, Dal Canto M, La Marca A, Carone D, Renzini MM, Webb R. The putative roles of FSH and AMH in the regulation of oocyte developmental competence: from fertility prognosis to mechanisms underlying age-related subfertility. Hum Reprod Update. 2022;28:232–54. https://doi.org/10.1093/humupd/dmab044 .
doi: 10.1093/humupd/dmab044
pubmed: 34969065
Trout SW, Seifer DB. Do women with unexplained recurrent pregnancy loss have higher day 3 serum FSH and estradiol values? Fertil Steril. 2000;74:335–7. https://doi.org/10.1016/S0015-0282(00)00625-7 .
doi: 10.1016/S0015-0282(00)00625-7
pubmed: 10927054
Kline JK, Kinney AM, Levin B, Kelly AC, Ferin M, Warburton D. Trisomic pregnancy and elevated FSH: implications for the oocyte pool hypothesis. Hum Reprod. 2011;26:1537–50. https://doi.org/10.1093/humrep/der091 .
doi: 10.1093/humrep/der091
pubmed: 21467203
pmcid: 3140264
Kline J, Kinney A, Reuss ML, Kelly A, Levin B, Ferin M, Warburton D. Trisomic pregnancy and the oocyte pool. Hum Reprod. 2004;19:1633–43. https://doi.org/10.1093/humrep/deh310 .
doi: 10.1093/humrep/deh310
pubmed: 15166127
Nasseri A, Mukherjee T, Grifo JA, Noyes N, Krey L, Copperman AB. Elevated day 3 serum follicle stimulating hormone and/or estradiol may predict fetal aneuploidy. Fertil Steril. 1999;71:715–8. https://doi.org/10.1016/S0015-0282(98)00525-1 .
doi: 10.1016/S0015-0282(98)00525-1
pubmed: 10202884
Massie JA, Burney RO, Milki AA, Westphal LM, Lathi RB. Basal follicle-stimulating hormone as a predictor of fetal aneuploidy. Fertil Steril. 2008;90:2351–5. https://doi.org/10.1016/j.fertnstert.2007.10.041 .
doi: 10.1016/j.fertnstert.2007.10.041
pubmed: 18178189
Thum MY, Abdalla HI, Taylor D. Relationship between women’s age and basal follicle-stimulating hormone levels with aneuploidy risk in in vitro fertilization treatment. Fertil Steril. 2008;90:315–21. https://doi.org/10.1016/j.fertnstert.2007.06.063 .
doi: 10.1016/j.fertnstert.2007.06.063
pubmed: 17953958
Hammoud I, Vialard F, Bergere M, Albert M, Gomes DM, Adler M, Malagrida L, Bailly M, Wainer R, Selva J. Follicular fluid protein content (FSH, LH, PG4, E2 and AMH) and polar body aneuploidy. J Assist Reprod Genet. 2012;29:1123–34. https://doi.org/10.1007/s10815-012-9841-8 .
doi: 10.1007/s10815-012-9841-8
pubmed: 22890422
pmcid: 3492586
Muasher SJ, Oehninger S, Simonetti S, Matta J, Ellis LM, Liu H-C, Jones GS, Rosenwaks Z. The value of basal and/or stimulated serum gonadotropin levels in prediction of stimulation response and in vitro fertilization outcome. Fertil Steril. 1988;50:298–307. https://doi.org/10.1016/s0015-0282(16)60077-8 .
doi: 10.1016/s0015-0282(16)60077-8
pubmed: 3135206
Scott RT, Toner JP, Muasher SJ, Oehninger S, Robinson S, Rosenwaks Z. Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. Fertil Steril. 1989;51:651–4. https://doi.org/10.1016/j.fertnstert.2019.08.086 .
doi: 10.1016/j.fertnstert.2019.08.086
pubmed: 2494082
Martin JS, Nisker JA, Tummon IS, Daniel SA, Auckland JL, Feyles V. Future in vitro fertilization pregnancy potential of women with variably elevated day 3 follicle-stimulating hormone levels. Fertil Steril. 1996;65:1238–40. https://doi.org/10.1016/s0015-0282(16)58347-2 .
doi: 10.1016/s0015-0282(16)58347-2
pubmed: 8641506
Sharif K, Elgendy M, Lashen H, Afnan M. Age and basal follicle stimulating hormone as predictors of in vitro fertilisation outcome. Br J Obstet Gynaecol. 1998;105:107–12. https://doi.org/10.1111/j.1471-0528.1998.tb09360.x .
doi: 10.1111/j.1471-0528.1998.tb09360.x
pubmed: 9442172
Buratini J, Dal Canto M, De Ponti E, Brambillasca F, Brigante C, Gippone S, Mignini Renzini M, La Marca A. Maternal age affects the relationship of basal FSH and anti-Mullerian hormone concentrations with post-ICSI/IVF live birth. Reprod Biomed Online. 2021. https://doi.org/10.1016/j.rbmo.2020.12.005 .
doi: 10.1016/j.rbmo.2020.12.005
pubmed: 33653653
Brown JR, Liu HC, Sewitch KF, Rosenwaks Z, Berkeley AS. Variability of day 3 follicle-stimulating hormone levels in eumenorrheic women. J Reprod Med. 1995;40(620–4):8576876.
Jain T, Klein NA, Lee DM, Sluss PM, Soules MR. Endocrine assessment of relative reproductive age in normal eumenorrheic younger and older women across multiple cycles. Am J Obstet Gynecol. 2003;189:1080–4. https://doi.org/10.1067/s0002-9378(03)00583-0 .
doi: 10.1067/s0002-9378(03)00583-0
pubmed: 14586359
Arslan AA, Zeleniuch-Jacquotte A, Lukanova A, Rinaldi S, Kaaks R, Toniolo P. Reliability of follicle-stimulating hormone measurements in serum. Reprod Biol Endocrinol. 2003;1:1–5. https://doi.org/10.1186/1477-7827-1-49 .
doi: 10.1186/1477-7827-1-49
Brink HV, Chizen D, Hale G, Baerwald A. Age-related changes in major ovarian follicular wave dynamics during the human menstrual cycle. Menopause. 2013;20:1243–54. https://doi.org/10.1097/GME.0b013e31828cfb62 .
doi: 10.1097/GME.0b013e31828cfb62
Baerwald A, Vanden Brink H, Hunter C, Beuker D, Lim H, Lee CH, Chizen D. Age-related changes in luteal dynamics: preliminary associations with antral follicular dynamics and hormone production during the human menstrual cycle. Menopause. 2018;25:399–407. https://doi.org/10.1097/GME.0000000000001021 .
doi: 10.1097/GME.0000000000001021
pubmed: 29112593
Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update. 2006;12:685–718. https://doi.org/10.1093/humupd/dml034 .
doi: 10.1093/humupd/dml034
pubmed: 16891297
Palermo G, Joris H, Devroey P, Van Steirteghem AC. Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte. The Lancet. 1992;340:17–8. https://doi.org/10.1016/0140-6736(92)92425-F .
doi: 10.1016/0140-6736(92)92425-F
Garcia-Pascual CM, Navarro-Sanchez L, Navarro R, Martinez L, Jimenez J, Rodrigo L, Simon C, Rubio C. Optimized NGS approach for detection of aneuploidies and mosaicism in PGT-A and imbalances in PGT-SR. Genes (Basel). 2020;11. https://doi.org/10.3390/genes11070724 .
Consortium EP, Group SI-EBW, Kokkali G, Coticchio G, Bronet F, Celebi C, Cimadomo D, Goossens V, Liss J, Nunes S, et al. ESHRE PGT Consortium and SIG Embryology good practice recommendations for polar body and embryo biopsy for PGT. Hum Reprod Open. 2020;2020:hoaa020. https://doi.org/10.1093/hropen/hoaa020 .
doi: 10.1093/hropen/hoaa020
Bancsi LF, Broekmans FJ, Looman CW, Habbema JD, te Velde ER. Predicting poor ovarian response in IVF: use of repeat basal FSH measurement. J Reprod Med. 2004;49:187–94. 15098888.
Ciepiela P, Duleba AJ, Kario A, Chelstowski K, Branecka-Wozniak D, Kurzawa R. Oocyte matched follicular fluid anti-Mullerian hormone is an excellent predictor of live birth after fresh single embryo transfer. Hum Reprod. 2019;34:2244–53. https://doi.org/10.1093/humrep/dez186 .
doi: 10.1093/humrep/dez186
pubmed: 31725884
Bernstein LR, Mackenzie ACL, Durkin K, Kraemer DC, Chaffin CL, Merchenthaler I. Maternal age and gonadotrophin elevation cooperatively decrease viable ovulated oocytes and increase ootoxicity, chromosome-, and spindle-misalignments: ‘2-Hit’ and ‘FSH-OoToxicity’ mechanisms as new reproductive aging hypotheses. Mol Hum Reprod. 2003;29:gaad030. https://doi.org/10.1093/molehr/gaad030 .
doi: 10.1093/molehr/gaad030
Combelles CM, Carabatsos MJ, Kumar TR, Matzuk MM, Albertini DF. Hormonal control of somatic cell oocyte interactions during ovarian follicle development. Mol Reprod Dev. 2004;69:347–55. https://doi.org/10.1002/mrd.20128 .
doi: 10.1002/mrd.20128
pubmed: 15349847
Richani D, Dunning KR, Thompson JG, Gilchrist RB. Metabolic co-dependence of the oocyte and cumulus cells: essential role in determining oocyte developmental competence. Hum Reprod Update. 2021;27:27–47. https://doi.org/10.1093/humupd/dmaa043 .
doi: 10.1093/humupd/dmaa043
pubmed: 33020823
Buratini J, Dellaqua TT, de Lima PF, Renzini MM, Canto MD, Price CA. Oocyte secreted factors control genes regulating FSH signaling and the maturation cascade in cumulus cells: the oocyte is not in a hurry. J Assist Reprod Genet. 2023;40:1961–71. https://doi.org/10.1007/s10815-023-02822-y .
doi: 10.1007/s10815-023-02822-y
pubmed: 37204638